drugset / Trial / NCT01693315

Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma

NCT01693315 ↗

Phase 2 Completed 82 enrolled Amakem, NV
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The objective of this dose-escalation study is to evaluate the safety, tolerability and efficacy of AMA0076 in reduction of intraocular pressure in subjects with ocular hypertension or primary open-angle glaucoma.

Timeline

Start
2012-09
Primary completion
2013-07
Completion
2013-07

Drugs

EvaluationDrugModalityDoseRoute
Subject AMA0076 Unknown — Topical